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1. Introduction
  
   Diabetes mellitus is an epidemic occurring in adults 
throughout the world and is the leading cause of kidney 
failure, heart attack, blindness and lower limb amputation. 
It is the fourth main cause of death in most developed 
countries. The prevalence of diabetes is estimated to reach 
330 million by the year 2025, according to International 
Diabetes Federation, with the greatest potential increase 
being in Africa and Asia. This numerical increase will 
occur in developing countries. By the year 2025, over 75% of 
people with diabetes will reside in developing countries, as 
compared to 62% in 1995[1].
   Currently available therapies for diabetes include 
insulin and various oral antidiabetic agents such as 
sulfonylureas, biguanides and glinides. Many of them have 
a number of serious adverse effects; therefore, the search 
for more effective and safer hypoglycemic agents is one 
PEER REVIEW                            ABSTRACT
KEYWORDS
Melastoma malabathricum, Antidiabetic, Antihyperlipidaemic, Alloxan, Glibenclamide, SGOT, 
SGPT, HbA1c
Objective: To evaluate the antidiabetic and antihyperlipidaemic effect of ethanol extract of 
Melastoma malabathricum (M. malabathricum) Linn. leaf in alloxan induced diabetic rats. 
Methods: Diabetes was induced in albino rats by administration of alloxan monohydrate (150 
mg/kg i.p). the ethanol extracts of M. malabathricum at a dose of 150 and 300 mg/kg of body 
weight were administrated at a single dose per day to diabetes induced rats for a period of 14 d. 
The effect of ethanol extract of M. malabathricum leaf extract on blood glucose, plasma insulin, 
creatinine, glycosylated haemoglobin, urea serum lipid profile [total cholesterol, triglycerides, 
low density lipoprotein-cholesterol, very low density lipoprotein-cholesterol, high density 
lipoprotein-cholesterol and phospholipid, serum protein, albumin, globulin, serum enzymes 
(serum glutamate pyruvate transaminases), serum glutamate oxaloacetate transaminases, and 
alkaline phosphatase] were measured in the diabetic rats. 
Results: In the acute toxicity study, ethanol extract of M. malabathricum leaf was non-toxic 
at 2 000 mg/kg in rats. The increased body weight, decreased blood glucose, glycosylated 
haemoglobin and other biochemical parameters level were observed in diabetic rats treated with 
both doses of ethanol extract of M. malabathricum leaf compared to diabetic control rats. In 
diabetic rats, ethanol extract of M. malabathricum leaf administration, altered lipid profiles were 
reversed to near normal than diabetic control rats. 
Conclusions: Ethanol extract of M. malabathricum leaf possesses significant antidiabetic and 
antihyperlipidaemic activity in diabetic rats. 
Peer reviewer
Dr. K. Arumugasamy, Associate 
Professor in Botany, PG&Research 
Department of Botany, Kongunadu 
College of Arts &Science, G. Mill Post 
Coimbatore, Tamil Nadu, India.
Tel: 919994963696
E-mail: arumugasamy_kasc@yahoo.
co.in
Comments
This a good study in which the authors 
validated that, M. malabathricum 
leaf is a potential antidiabetic drug 
that may be used for maintaining 
traditional use.
Details on Page S447
Article history:
Received 9 Jan 2014
Received in revised form 16 Jan, 2nd revised form 20 Jan, 3rd revised form 2 Feb 2014 
Accepted 18 Feb 2014 
Available online 28 Mar 2014
Karuppasamy Balamurugan et al./Asian Pac J Trop Biomed 2014; 4(Suppl 1): S442-S448 S443
of the important areas of investigations[2]. Many herbs and 
plants have been described as possessing hypoglycemic 
activity when taken orally[3]. According to the World Health 
Organization, there are more than 1 200 plant species 
worldwide used in the treatment of diabetes mellitus and 
substantial number of plant showed effective hypoglycemic 
activity after laboratory testing[4].
   Recently, some medicinal plants have been reported 
to be useful in diabetes worldwide and have been used 
empirically in antidiabetic and antihyperlipidemic 
remedies. Antihyperglycemic activity of the plants is 
mainly due to their ability to restore the function of 
pancreatic tissues by causing an increase in insulin output 
or inhibiting the intestinal absorption of glucose or to the 
facilitation of metabolites in insulin dependent processes. 
More than 400 plant species having hypoglycemic activity 
have been available in literature, however, searching for 
new antidiabetic drugs from natural plants is still attractive 
because they contain substances which demonstrate 
alternative and safe effects on diabetes mellitus. Most 
of the plants contain glycosides, alkaloids, terpenoids, 
flavonoids, carotenoids etc. that are frequently implicated as 
having antidiabetic effect[5]. However, the study of plant for 
hypoglycemic, antioxidant and hypolipidemic activities may 
give new pharmacological approaches in the treatment of 
diabetes mellitus[6].  
   Melastoma malabathricum (M. malabathricum) Linn. 
belongs to the Melastomataceae family. It is also called the 
Singapore Rhododendron or Sendudok. It is an erect shrub 
or small tree with the height of 1.5 to 5 m. It was traditionally 
used to treat diarrhoea, dysentery, leucorrhoea, hemorrhoids, 
wounds, infection during confinement, toothache, flatulence, 
sore legs, and thrush and it is also used by the Jah hut 
people in Malaysia to cure diarrhea[7]. There is no report on 
the antidiabetic and antihyperlipidaemic potential of this 
plant extract so far. The main objective of this study was 
to assess the antidiabetic and antihyperlipidaemic effect 
of ethanol extracts of leaf of M. malabathricum in alloxan 
induced diabetic rats.
2. Materials and methods
2.1. Plant material
   The leaves of M. malabathricum were freshly collected 
from Daudeli, Joide Taluk, Hubli district, North Karnataka. 
With the help of local flora, a voucher specimen was 
retained in Ethnopharmacology Unit, Research Department 
of Botany, V. O. Chidambaram College, Tuticorin for further 
reference. 
2.2. Preparation of plant extract for phytochemical screening 
and antidiabetic studies
   The M. malabathricum leaf was shade dried at room 
temperature and the dried leaf was powdered in a Wiley 
mill. Hundred grams of powdered leaf was packed in a 
Soxhlet apparatus and extracted with ethanol. The extracts 
were subjected to qualitative test for the identification of 
various phytochemical constituents as per the standard 
procedures[8,9]. The ethanol extracts were concentrated in a 
rotary evaporator. The concentrated ethanol extracts were 
used for antidiabetic studies.
2.3. Animals
   Normal healthy male Wistar albino rats (180-240 g) 
were housed under standard environmental conditions 
at temperature (25依2) °C and light and dark (12:12 h). Rats 
were fed with standard pellet diet (Goldmohur brand, MS 
Hindustan lever Ltd., Mumbai, India) and water ad libitum. 
Study was carried out as per IAFC approval No: 82/PHARMA/
SCRI, 2010.
2.4. Acute toxicity study
   Acute oral toxicity study was performed as per 
Organization for Economic Co-operation and Development-
423 guidelines (acute toxic class method), albino rats (n=6) of 
either sex selected by random sampling were used for acute 
toxicity study[10]. The animals were kept fasting for overnight 
and provided only with water, after which the extracts 
were administered orally at 5 mg/kg body weight by gastric 
intubations and observed for 14 d. If mortality was observed 
in two out of three animals, then the dose administered was 
assigned as toxic dose. If mortality was observed in one 
animal, then the same dose was repeated again to confirm 
the toxic dose. If mortality was not observed, the procedure 
was repeated for higher doses such as 50, 100, and 2 000 mg/
kg body weight. 
2.5. Induction of diabetes in experimental animal
   Rats were induced diabetes by the administration of 
simple intraperitoneal dose of alloxan monohydrate (150 
mg/kg)[11]. After 2 d of alloxan injection, rats screened for 
diabetes having glycosuria and hypoglycemia with blood 
glucose level of 200-260 mg/100 mL were taken for the study. 
All animals were allowed free access to water and pellet diet 
and maintained at room temperature in plastic cages. 
2.6. Experimental design
   In the present investigation, a total of 30 rats (24 diabetic 
surviving rats and six normal rats) were taken and divided 
into five groups of six rats each. Group I: normal untreated 
rats; Group II: diabetic control rats; Group III: diabetic rats 
given ethanol extract of M. malabathricum leaf (150 mg/kg 
body weight); Group IV: diabetic rats given ethanol extract 
of M. malabathricum leaf (300 mg/kg body weight); Group V: 
diabetic rats given standard drug glibenclamide (600 µg/kg 
body weight).
   The animals were sacrificed at the end of experimental 
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period of 14 d by decapitation. Blood was collected, sera 
separated by centrifugation at 3 000 g for 10 min.
2.6.1. Estimation of insulin, glucose, urea, creatinine and 
glycosylated haemoglobin
   Serum glucose was measured by the o-toluidine 
method[12]. Insulin level was assayed by ELISA kit[13]. Urea 
estimation was carried out by the method of Varley[14]; serum 
creatinine was estimated by the method of Owen et al[15]. 
Glycosylated haemoglobin (HbA1c) estimation was carried 
out by a modified colorimetric method of Karunanayake and 
Chandrasekharan[16].
2.6.2. Estimation of protein, albumin, globulin, SGPT, SGOT, 
ALP
   Serum protein[17] and serum albumins were determined by 
quantitative colorimetrically method by using bromocresol 
green. The total protein minus the albumin gives the 
globulin, serum glutamate pyruvate transaminase (SGPT) 
and serum glutamate oxaloacetate transaminase (SGOT) was 
measured spectrophotometrically by utilizing the method of 
Reitman and Frankel[18]. Serum alkaline phosphatase (ALP) 
was measured by the method of King and Armstrong[19].
2.6.3. Estimation of lipids and lipoprotein
   Serum total cholesterol (TC)[20], total triglycerides (TG)[21], 
low density lipoprotein cholesterol (LDL-C), very low density 
lipoprotein cholesterol (VLDL- C)[22], high density lipoprotein 
cholesterol (HDL-C)[23] and phospholipids[24] were analyzed.
2.7. Statistical analysis
   The data were analyzed using Student’s t-test statistical 
methods. For the statistical tests, P values less than 0.01 and 
0.05 were taken as significant.
3. Result
3.1. Phytochemical constituents 
   The phytochemical screening of ethanol extract of M. 
malabathricum leaf revealed the presence of alkaloid, 
catechin, coumarin, flavonoid, phenol, saponin, steroid, 
tannin, terpenoid, sugar, glycoside and xanthoprotein.
3.2. Acute toxicity test
   The extract was safe up to a dose of 2 000 mg/kg body 
weight. Behavior of the animals was closely observed for 
the first 8 h then at an interval of every 4 h during the next 
48 h, the extract did not cause mortality on rats during 48 h 
observation or any behavioral change.
3.3. Body weight and fasting blood glucose 
   In the present study, alloxan induced diabetic rats showed 
significant (P<0.01) reduction in body weight. Administration 
of ethanol extract of M. malabathricum leaf (150 and 300 mg/kg) 
and glibenclamide (600 mg/kg) significantly (P<0.05) increased 
the body weight within 14 d (Table 1). Fasting blood glucose 
levels of the diabetic control rats were higher than those of 
normal rats. A significant (P<0.05) dose dependent decrease 
in blood glucose levels was observed in the diabetic treated 
group from an initial level of 232.14 mg/dL to the level of 
144.36 mg/dL and from 213.12 mg/dL to 124.33 mg/dL after the 
treatment at a dose of 150 mg/kg and 300 mg/kg respectively 
for 14 d (Table 1).
3.4. Blood glucose level and other parameters
   Table 2 shows the levels of blood glucose, serum insulin, 
urea, creatinine and glycosylated hemoglobin of normal, 
diabetic control and drug treated rats. There was a 
significant (P<0.01) increase blood glucose level in alloxan 
induced diabetic rats (Group II) when compared with 
normal rats (Group I). Administration of leaf extract of M. 
malabathricum (Groups III & IV) and glibenclamide (Group 
V) tended to bring the parameters significantly (P<0.05, 
P<0.01) towards the normal. Serum insulin level of diabetic 
control group was significantly (P<0.01) decreased when 
compared to normal control group (Group I). The extract and 
glibenclamide group of diabetic rats significantly (P<0.01) 
increased the serum insulin. A significant (P<0.05) elevation 
in urea and creatinine was observed in alloxan induced 
diabetic rats (Group II) when compared to control rats. 
The M. malabathricum extracts were administrated orally 
to diabetic rats for 14 d reversed the urea and creatinine 
level to near normal. Administration of ethanol extract 
of M. malabathricum leaf (300 mg/kg) and glibenclamide 
significantly (P<0.05) reduced HbA1c level compared to 
Table 1
Effect of M. malabathricum leaf extract on the body weight and fasting blood glucose in normal, diabetic and diabetic treated rats. 
Treatment groups Mean initial body weight (g) Mean final body weight (g) 
Mean weight Gain 
(G↑)/loss (L↓) (g) 
Fasting bloodglucose (mg/dL) 
Initial Final (after 14 d)
Group I 189.54依5.11 197.65依6.36 8.12↑   69.88依1.92   73.95依1.64
Group II 192.63依8.24 173.94依5.24  18.69↓** 248.56依2.84 263.16依5.36
Group III 188.31依5.36 196.47依4.14  8.16↑a 232.14依2.54 144.36依4.86b
Group IV 184.51依5.33 194.93依4.38 10.42↑a 213.12依5.28 124.33依4.37b
Group V 196.58依9.34 216.42依7.39 19.84↑a 229.66依6.16 104.53依4.35b
Values are expressed as mean依SEM, n=5. **: P<0.05 comparison with normal control v.s. diabetic and drug treated; a: P<0.05 diabetic control v.s. 
drug treated; b: P<0.05 comparison with initial v.s. final.
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diabetic control rats.
3.5. Biochemical parameters
   The level of total protein, albumin, globulin and liver 
marker enzymes such as SGPT, SGOT and ALP in the serum of 
diabetic rats are presented in Table 3. Significant reductions 
in serum protein, albumin and globulin were observed in 
alloxan induced diabetic rats (Group II) when compared to 
control rats (Group I). On administration of ethanol extract 
of M. malabathricum leaf to the diabetic rats, protein 
albumin and globulin levels were found to be restored in 
normal. Also, the SGPT, SGOT and ALP levels were elevated 
significantly in alloxan induced diabetic rats compared 
to control rats. Both the doses of M. malabathricum leaf 
extracts and glibenclamide treatment significantly reduced 
above parameters compared to diabetic control rats.
3.6. Lipid profiles
   Table 4 shows the levels of TC, TG, LDL-C, VLDL-C, HDL-C 
and phospholipid in the serum of diabetic rats showed 
significantly (P<0.01) increased serum lipid profiles except 
HDL-C when compared with normal rats. The ethanol extract 
of M. malabathricum leaf treated rats showed a significant 
(P<0.01, P<0.05) decrease in the content of lipid profiles 
when compared with diabetic induced rats. Similarly HDL-C 
level decreased in alloxan induced diabetic rats when 
compared with normal rats. Administration of ethanol extract 
of M. malabathricum leaf and glibenclamide to the diabetic 
rats. HDL-C level was found to be restored to normal.   
4. Discussion
   Diabetes mellitus is one of the most familiar chronic 
diseases associated with carbohydrate metabolism. It 
is also an indication of co-morbidities such as obesity, 
hypertension and hyperlipidemia which are metabolic 
complications of both clinical and experimental diabetes. 
Despite the fact that diabetes mellitus has high prevalence, 
morbidity, and mortality globally; it is regarded as a non 
curable but controllable disease. Different synthetic drugs, 
plant remedies and dietary modification play an efficient 
role in the reduction of the suffering that it causes. The 
potential role of medicinal plants as hypoglycemic agents 
has been reviewed by several researchers[25,26]. 
   Pancreas is the primary organ involved in sensing 
Table 2
Effect of M. malabathricum leaf extracts on the serum insulin, glucose, urea, creatinine and HbA1c level of normal, diabetic induced and drug 
treated rats.
Treatment groups Insulin (mIU/mL) Glucose (mg/dL) Urea (mg/dL) Creatinine (mg/dL) HbA1c (%)
Group I           21.830依1.130  73.81依3.54 12.05依1.04 0.73依0.12             4.61依0.52
Group II    9.190依0.948**   198.39依2.61**  29.63依1.85*  2.45依0.35*  9.89依0.25**
Group III 14.300依1.670a 134.66依1.56a 21.54依1.26 1.86依0.48  7.26依0.76ns
Group IV 18.510依1.250c     114.51依1.84c 14.45依1.38 1.29依0.15 5.16依0.81a
Group V 19.730依1.090c 109.38依1.84c  13.05依1.56a  1.05依0.11a 5.21依0.62a
Values are expressed as mean依SEM, n=5. *: comparison made between normal control to diabetic control and drug treated groups; *: P<0.05, **: 
P<0.01; a: comparison made between diabetic control to drug treated groups; a: P<0.05, c: P<0.01; ns: not significant.
Table 3
Effect of M. malabathricum leaf extracts on the serum protein, albumin, globulin, SGPT, SGOT and ALP level of normal, diabetic induced, and 
drug treated rats.
Treatment groups Protein (g/dL) Albumin (g/dL) Globulin (g/dL) SGPT (µ/L) SGOT (µ/L) ALP (µ/L) 
Group I 7.93依0.16 4.63依0.14 3.30依0.11 18.53依1.62 20.16依1.33 184.93依3.65
Group II 6.02依0.19*  3.84依0.21* 2.18依0.24  97.18依3.54*  89.25依1.91*  226.16依4.84*
Group III 6.96依0.15a 4.12依0.11 2.84依0.14 38.56依1.26 49.66依1.76  204.08依4.56a
Group IV 8.26依0.65a 4.86依0.53 3.40依0.52 27.59依1.84 30.51依1.94  191.56依2.89a
Group V 7.96依0.38ns 4.03依0.45 3.93依0.24 21.94依1.12 25.88依1.65  173.94依2.16a
Values are expressed as mean依SEM, n=5. *: comparison made between normal control to diabetic control and drug treated groups; *: P<0.05; a: 
comparison made between diabetic control to drug treated groups; a: P<0.05; ns: not significant.
Table  4
Effect of M. malabathricum leaf extracts on the serum lipid profile of normal, diabetic induced, and drug treated rats.
Treatment groups TC (mg/dL) TG (mg/dL) HDL (mg/dL) LDL-C (mg/dL) V-LDL (mg/dL) Phospholipid (mg/dL)
Group I 103.34依2.18 93.61依1.64 42.98依2.16 41.64依1.32 18.72依1.03 159.97依3.51
Group II   214.26依4.76**  198.16依4.27**    26.36依1.65**  148.27依3.68**  39.63依1.26*    258.69依5.33**
Group III  164.13依2.48c 156.31依1.74c  31.14依2.14a   96.64依1.34a  34.44依1.34a  224.36依2.36a
Group IV  141.65依2.27c 136.18依1.13c  36.39依2.31a   78.02依1.16c  27.24依1.48a  194.06依2.17a
Group V  119.57依1.21c 124.74依2.68c 23.54依1.88   71.08依1.21c  24.95依1.23a  174.41依1.92c
Values are expressed as mean依SEM, n=5. *: Comparison made between normal control to diabetic control and drug treated groups; *: P<0.05, **: 
P<0.01; a: comparison made between diabetic control to drug treated groups; a: P<0.05; c: P<0.01; ns: not significant.
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the organism’s dietary and energetic states via glucose 
concentration in the blood and in response to elevated blood 
glucose, insulin is secreted.
   Alloxan is one of the usual substances used for the 
induction of diabetes mellitus apart from streptozotocin. 
Alloxan has a destructive effect on the beta cells of the 
pancreas. 
   Alloxan causes a massive reduction in insulin release 
by the destruction of β-cells of the islets of langherhans, 
thereby inducing hyperglycemia. Insulin deficiency leads to 
various metabolic alterations in the animals viz. increased 
cholesterol, increased levels of alkaline phosphate and 
transaminases[27,28].
   In diabetic condition, elevated blood glucose, reduction 
in body weight, polyuria, polydipsia and polyphagia are 
commonly observed. In the present study, induction of 
diabetes by alloxan produced increase in blood glucose 
level, decrease in body weight and polyuria. In diabetic 
rats, observed reduction in body weight was possible due 
to catabolism of fats and protein[29]. The administration of 
ethanol extract of M. malabathricum leaf improves body 
weight compared to diabetic control rats which indicates 
preventive effect of M. malabathricum on degradation of 
structural proteins. The increase in blood glucose level after 
alloxan administration may be due to insulin deficiency or 
resistance state in diabetic rats. Administration of ethanol 
extract of M. malabathricum leaf significantly reduced 
blood glucose level in diabetic rats which represents 
reversal of insulin resistance or increasing insulin secretion 
possibly by regeneration of damaged pancreatic β-cells in 
alloxan-induced diabetic rats[30]. Earlier, many plants have 
been studied for their hypoglycemic and insulin release 
stimulatory effects[31-36]. 
   In diabetes, elevated levels of serum urea and creatinine 
are observed which may be due to renal damage caused 
by abnormal glucose regulation or elevated glucose and 
glycosylated protein tissue levels[37]. In present study, 
significant increase in serum urea and creatinine levels were 
observed in diabetic rats compared to normal control rats 
which indicate impaired renal function in diabetic rats. The 
treatment with ethanol extract of M. malabathricum lowered 
the above parameters significantly compared to diabetic 
control rats and it showed protective effect of ethanol extract 
of M. malabathricum on the kidneys. 
   In diabetes, HbA1c is considered as a diagnostic marker 
and helps to know about degree of protein glycation, long-
term blood sugar level and correlation of diabetes associated 
complications[38,39]. HbA1c has been found to be increased 
over a long period of time in diabetes. During diabetes, the 
excess of glucose present in blood reacts with haemoglobin 
to form glycosylated haemoglobin[40]. The rate of glycation 
is proportional to the concentration of blood glucose. 
In present study, alloxan induced diabetic rats showed 
significant increase (P<0.01) HbA1c level compared with 
normal rats. The ethanol extract of M. malabathricum whole 
plant treated rats showed a significant decrease (P<0.05) in 
the content of glycosylated haemoglobin that could be due to 
an improvement in glycemic status. 
   In diabetic condition, occurrence of reduction in protein 
and albumin may be due to proteinuria, albuminuria or 
increased protein catabolism, which are clinical markers 
in diabetic nephropathy[41]. The protein and albumin level 
was reduced after the induction of diabetes and treatment of 
ethanol extract of M. malabathricum increased both levels 
considerably in diabetic rats towards normal level. This 
action possibly is through increase in the insulin mediated 
amino acid uptake, enhancement of protein synthesis and/
or inhibition of protein degradation[42]. Also, increased 
serum SGOT, SGPT and ALP levels were reported in diabetes 
and it may be due to liver dysfunction[43]. In this study, 
increased level of SGOT, SGPT and ALP was observed in 
alloxan-induced diabetic rats which may have occurred 
by leakage of enzymes from the liver cytosol into the blood 
stream; it represents the toxicity of alloxan on liver. Diabetic 
rats treated with ethanol extract of M. malabathricum leaf 
significantly reduced both enzyme levels which represents 
the protective action of ethanol extract of M. malabathricum 
leaf in diabetic condition.
   The most common lipid abnormalities in diabetes are 
hypertriglyceridemia and hypercholesterolemia[44]. The 
abnormal high concentrations of serum lipids in diabetic 
animals are mainly due to an increased mobilization of 
free fatty acids from peripheral fat depots[45]. In the present 
study, significantly increased levels of serum TC, TG, V-LDL 
and LDL as well as marked reduction in serum HDL level in 
diabetic rats. Administration of both the doses of ethanol 
extract of M. malabathricum leaf decreased levels of TC, 
LDL, V-LDL and TG levels as well as increased the level of 
HDL in diabetic rats. The above action could be beneficial 
in preventing diabetic complications such as coronary heart 
diseases and atherosclerosis in diabetic condition. Increased 
phospholipids levels in serum were reported by Anitha et 
al. in alloxan induced diabetic rats[46]. Administration of 
ethanol extract of M. malabathricum leaf glibenclamide 
decreased the levels of phospholipids.
   In the present study, the administration of M. 
malabathricum  leaf  extracts  to  al loxan induced 
hyperglycemic rats demonstrated prominent reduction 
in blood sugar level, normalization of serum biochemical 
profile including lipid content, as compared to alloxan 
control rats. The phytochemical analysis has shown the 
presence of potent phytochemicals such as flavonoids, 
terpenoids, glycosides, steroids, saponin and phenols. 
Several authors reported that flavonoids, steroids/
terpenoids, phenolic acids are known to be bioactive 
antidiabetic principles[47,46]. Flavonoids are known to 
regenerate the damaged beta cells in the alloxan induced 
diabetic rats and acts as insulin secretagogues[48]. In the 
present study, the phytochemical analysis of ethanol extract 
of M. malabathricum leaf clearly prints out the presence of 
above said active principles. The preliminary investigation 
on the antihyperglycemic, antihyperlipidaemic and 
antioxidant efficacy of ethanol extract of M. malabathricum 
leaf will be significant to proceed further in this path for the 
isolation of active principles responsible for the antidiabetic 
activity.
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Comments 
Background
   Diabetes mellitus is still not completely curable by current 
antidiabetic drugs. Insulin therapy is the only satisfactory 
approach in diabetes mellitus, even though it has several 
drawbacks such as insulin resistance, anorexia, brain 
atrophy and fatty liver in chronic treatment. Treatment of 
type 2 diabetes mellitus patients with sulfonylureas and 
biguanides is always associated with side effects. So, herbal 
drugs are gaining popularity in the treatment of diabetes 
mellitus. The major merits of herbal medicines seem to be 
their efficacy, low incidence of side effects, and low cost. 
The paper is on analytical report of M. malabathricum leaf 
ethanolic extract. Relevant established protocol were used to 
analyse the antidiabetic and antihyperlipidaemic activity of 
ethanolic extract of the plant.
  
Research frontiers
   Many traditional plant treatments for diabetes are used 
through out the world. Plant drugs and herbal formulations 
are frequently considered to be less toxic and free 
from side effects than synthetic one. Based on the WHO 
recommendations, hypoglycemic agents of plant origin used 
in traditional medicine are important.
Related Reports
   Similar work has been done earlier in other plants using 
the same methodology.
Innovations and breakthroughs
   The present study indicates that ethanolic extract of M. 
malabathricum leaf decreased the blood glucose levels in 
diabetic rats and increased the insulin level. 
  
Applications
   The results of this study give scientific credibility to the 
use of the plant M. malabathricum leaf in the treatment of 
many diabetics.
Peer review
   This a good study in which the authors validated that, M. 
malabathricum leaf is a potential antidiabetic drug that may 
be used for maintaining traditional use.
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